3D Systems acquires Volumetric Biotechnologies, Inc.

3D Systems acquired Volumetric Biotechnologies, Inc. for $40.172 million ($24.814M cash + ~$15.358M stock; milestone payments up to $355M), a transaction completed in December 2021, structured as Stock/asset acquisition, cash and stock with contingent milestone payments.

Volumetric Biotechnologies, Inc. operates in Healthcare / Regenerative Medicine, is based in United States (Houston, TX). Biotech company whose mission is to develop the ability to manufacture human organs using bioprinting methods and the underlying technologies required to create highly complex biological structures.

Expand capabilities and capacity in bioprinting and regenerative medicine, accelerating human organ bioprinting strategy.

Part of the Healthcare reporting unit and segment.

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.